ADVIA CENTAUR XPT ACTIVE-B12 (HOLOTRANSCOBALAMIN) (AB12) N/A 10995088

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-10-16 for ADVIA CENTAUR XPT ACTIVE-B12 (HOLOTRANSCOBALAMIN) (AB12) N/A 10995088 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[126090821] All test results are analysed with reagent lot 32689016. The customer noticed variation/bias within ab12 reagent lot 32689016 in the low end of results in quality contol (qc) and with patient results. The reagent is not homogenous, particles/sediment can be seen in the bottom of the reagent readypack from the last two shipments. The same lot has been performing as specified earlier. The customer is calibrating ab12 assay more often and is also running qc as well. The customer received ab12 lot 33437017 for troubleshooting. The low control result on the advia centaur xpt 3 was 13. 9 and the next morning the result was 20. The ranges for ab12 qc results are 11. 7 to 19. 5 for the low control and 45. 3 to 75. 5 for the high control. The reagent seemed to have also a sediment in the bottom of the reagent readypack. Siemens healthcare diagnostics is investigating the cause of the discordant ab12. The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[126090822] Discordant high advia centaur xpt active-b12 (holotranscobalamin) (ab12) results were obtained on a patient sample. The customer observed the reagent is not homogenous, particles/sediment can be seen in the bottom of the reagent readypack for lot 32689016. The initial testing was on (b)(6) 2018 and the repeat testing was on (b)(6) 2018. The results were not reported to the physician. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the ab12 discordant results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2018-00258
MDR Report Key7970421
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-10-16
Date of Report2019-01-07
Date of Event2018-09-14
Date Mfgr Received2018-12-20
Date Added to Maude2018-10-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XPT ACTIVE-B12 (HOLOTRANSCOBALAMIN) (AB12)
Generic NameAB12 IMMUNOASSAY
Product CodeCDD
Date Received2018-10-16
Model NumberN/A
Catalog Number10995088
Lot Number32689016
Device Expiration Date2019-03-13
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2018-10-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.